These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 6086873)
1. Molecular basis for the cardiovascular activities of amrinone and AR-L57. Hayes JS; Bowling N; Boder GB; Kauffman R J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873 [TBL] [Abstract][Full Text] [Related]
2. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100. Hayes JS; Wyss VL; Wilson HC; Robertson DW; Kauffman RF J Pharmacol Exp Ther; 1986 Nov; 239(2):375-81. PubMed ID: 3021955 [TBL] [Abstract][Full Text] [Related]
3. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA; Johnson DC Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [TBL] [Abstract][Full Text] [Related]
4. Roles for Ca++ and cyclic AMP in mediating the cardiotonic actions of isomazole (LY175326). Hayes JS; Bowling N; Pollock GD; Robertson DW J Pharmacol Exp Ther; 1986 Apr; 237(1):18-24. PubMed ID: 3007737 [TBL] [Abstract][Full Text] [Related]
5. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Endoh M; Yanagisawa T; Taira N; Blinks JR Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308 [TBL] [Abstract][Full Text] [Related]
7. Effect of amrinone on sodium-calcium exchange in cardiac sarcolemmal vesicles. Mallov S Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):197-210. PubMed ID: 6635316 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the cardiotonic effects of AR-L115 and AR-L57: evidence for distinct inotropic mechanisms. Hayes JS; Wyss VL; Wilson H; Pollock GD J Cardiovasc Pharmacol; 1985; 7(1):182-9. PubMed ID: 2580141 [TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals. Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464 [TBL] [Abstract][Full Text] [Related]
11. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy. Bassett AL; Gaide MS; Lodge NJ; Cameron JS Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264 [TBL] [Abstract][Full Text] [Related]
12. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663 [TBL] [Abstract][Full Text] [Related]
13. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism. Ahn HS; Eardley D; Watkins R; Prioli N Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728 [TBL] [Abstract][Full Text] [Related]